Poland Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare) ... Read more
|
Major Players
|
Poland Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Poland was valued at USD 830 million in 2025 and is estimated at USD 870 million in 2026.
- The market size is expected to grow to USD 960 million by 2032.
- Market to register a CAGR of around 2.1% during 2026-32.
- Product Shares
- Systemic analgesics grabbed market share of 90%.
- Competition
- More than 20 companies are actively engaged in producing analgesics in Poland.
- Top 5 companies acquired around 45% of the market share.
- Bayer Sp zoo, Johnson & Johnson Poland Sp zoo, Sandoz Polska Sp zoo, US Pharmacia Sp zoo, GSK Consumer Healthcare etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 90% of the market.
Poland Analgesics Market Outlook
Poland analgesics market size was valued at USD 830 million in 2025 and is projected to grow from USD 870 million in 2026 to USD 960 million by 2032, exhibiting a CAGR of 2.1% during the forecast period. Growth remains steady as consumer demand stays stable in this mature category, while improving economic conditions reduce the degree of trading down and support better value performance for established pain relief products.
Demand remains supported by Poland’s ageing population, which keeps the need for pain relief visible across daily self care. Older adults are more likely to experience joint pain, back pain, and other recurring discomforts, which supports regular use of analgesics. Consumers also continue to trust familiar and well known brands for reliable ingredients and effective relief, which helps maintain stable demand across the category.
By product, systemic analgesics hold the leading share at around 90%, supported by strong reliance on oral pain relief for headaches, fever, joint pain, and other common discomforts. At the same time, the category remains price sensitive because these products are bought frequently and consumers notice price increases quickly. This keeps affordability important and encourages comparison with cheaper alternatives, including private label products that compete directly with established brands.
By sales channel, retail offline leads with around 90% share, as physical pharmacies remain the preferred place to buy analgesics because of quick access, trust, and convenience. Strong store based availability keeps offline purchasing central to the category. At the same time, heavy television advertising continues to support consumer awareness, helping brands stay visible and reinforcing regular purchase patterns across the forecast period.

Poland Analgesics Market Growth DriverAgeing Population Keeps Pain Relief Demand Steady
A growing older population continues to support analgesics demand in Poland. Older adults are more likely to face joint pain, back pain, and other recurring discomforts, which keeps everyday pain relief relevant in regular self care. This supports stable demand for well known analgesic products that consumers already trust for reliable and effective relief.
Statistics Poland’s latest older people publication, released in December 2025, shows that people aged 60 and over account for 26.6% of Poland’s population, while the old age dependency ratio reaches 31.8. The same source shows the median age rises to 43.3 in 2024, confirming the continued ageing of the population. This demographic structure keeps pain management needs visible across the country.
Poland Analgesics Market ChallengePrice Sensitivity Keeps Brand Competition Intense
Frequent use of pain relief products makes price changes highly visible in Poland. This creates a challenge for analgesics brands because consumers can quickly compare options and move toward cheaper alternatives when prices rise. It also makes it harder for premium products to defend their position when private label and lower priced offers remain easily available.
Official inflation data shows why affordability remains important. Statistics Poland reports that consumer prices in September 2025 are 2.9% higher than a year earlier, with goods up 1.9% and services up 5.8%. In a category bought repeatedly, even moderate price increases can influence brand choice and encourage switching to lower cost pain relief options.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Poland Analgesics Market TrendTelevision Advertising Continues to Shape Awareness
Television remains an important trend in how pain relief products reach consumers in Poland. Strong visibility on TV helps analgesics brands explain speed, convenience, and product benefits in a simple way, which keeps these products prominent in everyday consumer decision making. This supports continued brand recall and reinforces familiarity with established analgesic names.
Official audience data confirms that TV still has strong reach. The National Broadcasting Council reports that in Q3 2025, the average person in Poland watches television for 3 hours and 27 minutes per day, and the highest viewing period remains 18:00 to 23:00. This gives advertisers a broad and regular platform for consumer health messaging.
Poland Analgesics Market OpportunityImproving Consumer Spending Creates Better Value Potential
A firmer consumer spending environment creates room for stronger value performance in analgesics in Poland. When household conditions improve, consumers are under less pressure to trade down, which helps established and higher value brands hold demand more effectively. This creates an opening for analgesics positioned around quality, effectiveness, and added benefits such as anti inflammatory support.
Official data supports this spending backdrop. Statistics Poland reports that GDP in Q2 2025 is 3.4% higher year on year, while retail sales in January–December 2025 rise 4.3% year on year. It also reports the average monthly wage in February 2025 reaches PLN 9,362.47, up 11.2% in nominal terms from a year earlier.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Poland Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product is systemic analgesics, holding around 90% of the Poland analgesics market in value terms. This segment remains ahead because consumers continue to rely on familiar oral pain relief products for headaches, fever, joint pain, and other common discomforts. Strong trust in established active ingredients also keeps these products central to regular self care.
Its leading position is supported by the country’s ageing profile. Statistics Poland’s latest older people publication shows that people aged 60 and over account for 26.6% of the population, while the old age dependency ratio stands at 31.8. This older consumer base supports regular use of systemic analgesics for recurring aches and pains in everyday life.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel is retail offline, accounting for around 90% of the Poland analgesics market in value terms. This channel leads because consumers still rely mainly on physical pharmacies for quick access, trusted advice, and immediate purchase of pain relief products. Offline buying remains especially important for everyday medicines where reassurance and convenience matter.
Statistics Poland’s latest pharmacy release shows how strong this physical network remains. At the end of 2024, Poland has 11.2 thousand generally available pharmacies and 1.1 thousand pharmaceutical outlets, while online medicine sales are carried out by only 236 pharmacies and 8 pharmacy outlets. This wide store base keeps retail offline dominant in analgesics distribution.
List of Companies Covered in Poland Analgesics Market
The companies listed below are highly influential in the Poland analgesics market, with a significant market share and a strong impact on industry developments.
- Bayer Sp zoo
- Johnson & Johnson Poland Sp zoo
- Sandoz Polska Sp zoo
- US Pharmacia Sp zoo
- GSK Consumer Healthcare
- Zaklady Farmaceutyczne Polpharma SA
- Reckitt Benckiser Poland SA
- UPSA Laboratoires
- Omega Pharma Poland Sp zoo
- Pabianickie Zaklady Farmaceutyczne Polfa SA
Competitive Landscape
In 2025, analgesics in Poland recorded healthy constant value growth, supported by improving economic conditions which reduced trading down and reinforced demand for trusted, well-known brands. US Pharmacia Sp zoo led the market with an 18.3% value share, followed by GSK Consumer Healthcare at 11.9%, with strong consumer trust in brands such as Apap and Ibuprom. Products based on acetaminophen and aspirin continued to dominate volume sales, while dipyrone recorded the fastest growth as consumers sought stronger pain relief, with Pyralgina remaining a key brand. Demand was further supported by an ageing population and widespread advertising, particularly via television, highlighting rapid and effective relief. However, price sensitivity remained evident due to frequent usage, encouraging some consumers to shift towards more affordable options, including private label products promoted by pharmacy chains.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Poland Analgesics Market Policies, Regulations, and Standards
- Poland Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Poland Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Poland Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Poland Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- US Pharmacia Sp zoo
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GSK Consumer Healthcare
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Zaklady Farmaceutyczne Polpharma SA
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Reckitt Benckiser Poland SA
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- UPSA Laboratoires
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bayer Sp zoo
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Johnson & Johnson Poland Sp zoo
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Sandoz Polska Sp zoo
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Omega Pharma Poland Sp zoo
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Pabianickie Zaklady Farmaceutyczne Polfa SA
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- US Pharmacia Sp zoo
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











